Learn More
A new classification algorithm, called VFI5 (for Voting Feature Intervals), is developed and applied to problem of differential diagnosis of erythemato-squamous diseases. The domain contains records of patients with known diagnosis. Given a training set of such records, the VFI5 classifier learns how to differentiate a new case in the domain. VFI5(More)
BACKGROUND Several isolated observations have suggested that acne can develop in groups when a high glycemic index diet is adopted. OBJECTIVE This study was designed to examine associations among daily diet glycemic index, glycemic loads, serum insulin levels, and acne. METHODS A total of 49 patients with acne and 42 healthy control subjects were(More)
The incidence of depression in acne patients using isotretinoin was assessed in 100 patients with moderate and nodulocystic acne. All patients received 0.75-1.00 mg/kg/day of isotretinoin for 20-28 weeks after acne was assessed. All patients' acne lesions were improved at the end of the treatment period. Psychological state was evaluated at baseline, at(More)
Psoriasis is a chronic, recurrent, inflammatory, and hyperproliferative disease. Recently there have been studies regarding increases in the levels of NO in inflammatory dermatoses including psoriasis. In this study, 22 patients with psoriasis were scored with PASI (psoriasis area and severity index) and the levels of serum nitrite-nitrate were evaluated(More)
BACKGROUND Many current guidelines provide detailed evidence-based recommendations for acne treatment. OBJECTIVE To create consensus-based, simple, easy-to-use algorithms for clinical acne treatment in daily office-based practice and to provide checklists to assist in determining why a patient may not have responded to treatment and what action to take.(More)
BACKGROUND Treatment options for seborrheic dermatitis are numerous, including both topical and systemic agents (e.g. topical corticosteroids, oral antifungals, and psoralen plus UVA). However, long-term use of topical corticosteroids may lead to adverse effects. Pimecrolimus 1% cream is an effective and well tolerated treatment for seborrheic dermatitis.(More)